Thrombospondin 1 enhances systemic inflammation and disease severity in acute-on-chronic liver failure.
Hozeifa Mohamed HassanXi LiangJiaojiao XinYingyan LuQun CaiDongyan ShiKeke RenJun LiQi ChenJiang LiPeng LiBeibei GuoHui YangJinjin LuoHeng YaoXingping ZhouWen HuJing JiangJun LiPublished in: BMC medicine (2024)
THBS1 might be an ACLF disease development-related biomarker, promoting inflammatory responses and hepatocellular apoptosis, that could provide clinicians with a new molecular target for improving diagnostic and therapeutic strategies.